Cargando…
Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
[Image: see text] Many cancer drugs fail at treating solid epithelial tumors with hypoxia and insufficient drug penetration thought to be contributing factors to the observed chemoresistance. Owing to this, it is imperative to evaluate potential cancer drugs in conditions as close to in vivo as poss...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983004/ https://www.ncbi.nlm.nih.gov/pubmed/36700916 http://dx.doi.org/10.1021/jasms.2c00307 |
_version_ | 1784900453345001472 |
---|---|
author | Shortt, Raquel L. Wang, Yijia Hummon, Amanda B. Jones, Lisa M. |
author_facet | Shortt, Raquel L. Wang, Yijia Hummon, Amanda B. Jones, Lisa M. |
author_sort | Shortt, Raquel L. |
collection | PubMed |
description | [Image: see text] Many cancer drugs fail at treating solid epithelial tumors with hypoxia and insufficient drug penetration thought to be contributing factors to the observed chemoresistance. Owing to this, it is imperative to evaluate potential cancer drugs in conditions as close to in vivo as possible, which is not always done. To address this, we developed a mass spectrometry-based protein footprinting method for exploring the impact of hypoxia on protein in 3D colorectal cancer cells. Our group has previously extended the protein footprinting method fast photochemical oxidation of proteins (FPOP) for live cell analysis (IC-FPOP); however, this is the first application of IC-FPOP in a 3D cancer model. In this study, we perform IC-FPOP on intact spheroids (Spheroid-FPOP) using a modified version of the static platform incubator with an XY movable stage (PIXY) FPOP platform. We detected modification in each of three spheroid layers, even the hypoxic core. Pathway analysis revealed protein modifications in over 10 distinct protein pathways, including some involved in protein ubiquitination; a process modulated in cancer pathologies. These results demonstrate the feasibility of Spheroid-FPOP to be utilized as a tool to interrogate protein interactions within a native tumor microenvironment. |
format | Online Article Text |
id | pubmed-9983004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99830042023-03-04 Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids Shortt, Raquel L. Wang, Yijia Hummon, Amanda B. Jones, Lisa M. J Am Soc Mass Spectrom [Image: see text] Many cancer drugs fail at treating solid epithelial tumors with hypoxia and insufficient drug penetration thought to be contributing factors to the observed chemoresistance. Owing to this, it is imperative to evaluate potential cancer drugs in conditions as close to in vivo as possible, which is not always done. To address this, we developed a mass spectrometry-based protein footprinting method for exploring the impact of hypoxia on protein in 3D colorectal cancer cells. Our group has previously extended the protein footprinting method fast photochemical oxidation of proteins (FPOP) for live cell analysis (IC-FPOP); however, this is the first application of IC-FPOP in a 3D cancer model. In this study, we perform IC-FPOP on intact spheroids (Spheroid-FPOP) using a modified version of the static platform incubator with an XY movable stage (PIXY) FPOP platform. We detected modification in each of three spheroid layers, even the hypoxic core. Pathway analysis revealed protein modifications in over 10 distinct protein pathways, including some involved in protein ubiquitination; a process modulated in cancer pathologies. These results demonstrate the feasibility of Spheroid-FPOP to be utilized as a tool to interrogate protein interactions within a native tumor microenvironment. American Chemical Society 2023-01-26 /pmc/articles/PMC9983004/ /pubmed/36700916 http://dx.doi.org/10.1021/jasms.2c00307 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Shortt, Raquel L. Wang, Yijia Hummon, Amanda B. Jones, Lisa M. Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids |
title | Development of Spheroid-FPOP:
An In-Cell Protein Footprinting
Method for 3D Tumor Spheroids |
title_full | Development of Spheroid-FPOP:
An In-Cell Protein Footprinting
Method for 3D Tumor Spheroids |
title_fullStr | Development of Spheroid-FPOP:
An In-Cell Protein Footprinting
Method for 3D Tumor Spheroids |
title_full_unstemmed | Development of Spheroid-FPOP:
An In-Cell Protein Footprinting
Method for 3D Tumor Spheroids |
title_short | Development of Spheroid-FPOP:
An In-Cell Protein Footprinting
Method for 3D Tumor Spheroids |
title_sort | development of spheroid-fpop:
an in-cell protein footprinting
method for 3d tumor spheroids |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983004/ https://www.ncbi.nlm.nih.gov/pubmed/36700916 http://dx.doi.org/10.1021/jasms.2c00307 |
work_keys_str_mv | AT shorttraquell developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids AT wangyijia developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids AT hummonamandab developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids AT joneslisam developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids |